2008 ICD-9-CM Volume 1 Diagnosis Codes Home > Neoplasms 140-239 > Malignant Neoplasm Of Lymphatic And Hematopoietic Tissue 200-208 > Leukemia Of Unspecified Cell Type 208.* >  2008 ICD-9-CM Diagnosis 208.9
Unspecified leukemia- (loo-KEE-mee-a) Cancer of blood-forming tissue.
- A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years. -- 2004
- A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. It is classified according to degree of cell differentiation as acute or chronic, and according to predominant type of cell involved as myelogenous or lymphocytic. (Dorland, 28th ed)
- 208.9 is a non-specific code that cannot be used to specify a diagnosis
- 208.9 contains 3 index entries
- View the ICD-9-CM Volume 1 208.* hierarchy
208.9 also known as:
Index entries containing 208.9:- Bennett's
- disease (leukemia)
 208.9
Disease, diseased - see also Syndrome- Bennett's (leukemia) 208.9
Leukemia, leukemic (congenital) (M9800/3) 208.9- acute NEC (M9801/3) 208.0
- aleukemic NEC (M9804/3) 208.8
- granulocytic (M9864/3) 205.8
- basophilic (M9870/3) 205.1
- blast (cell) (M9801/3) 208.0
- blastic (M9801/3) 208.0
- granulocytic (M9861/3) 205.0
- chronic NEC (M9803/3) 208.1
- compound (M9810/3) 207.8
- eosinophilic (M9880/3) 205.1
- giant cell (M9910/3) 207.2
- granulocytic (M9860/3) 205.9
- hairy cell (M9940/3) 202.4
- hemoblastic (M9801/3) 208.0
- histiocytic (M9890/3) 206.9
- lymphatic (M9820/3) 204.9
- lymphoblastic (M9821/3) 204.0
- lymphocytic (M9820/3) 204.9
- lymphogenous (M9820/3) - see Leukemia, lymphoid
- lymphoid (M9820/3) 204.9
- lymphosarcoma cell (M9850/3) 207.8
- mast cell (M9900/3) 207.8
- megakaryocytic (M9910/3) 207.2
- megakaryocytoid (M9910/3) 207.2
- mixed (cell) (M9810/3) 207.8
- monoblastic (M9891/3) 206.0
- monocytic (Schilling-type) (M9890/3) 206.9
- monocytoid (M9890/3) 206.9
- monomyelocytic (M9860/3) - see Leukemia, myelomonocytic
- myeloblastic (M9861/3) 205.0
- myelocytic (M9863/3) 205.1
- myelogenous (M9860/3) 205.9
- myeloid (M9860/3) 205.9
- myelomonocytic (M9860/3) 205.9
- Naegeli-type monocytic (M9863/3) 205.1
- neutrophilic (M9865/3) 205.1
- plasma cell (M9830/3) 203.1
- plasmacytic (M9830/3) 203.1
- prolymphocytic (M9825/3) - see Leukemia, lymphoid
- promyelocytic, acute (M9866/3) 205.0
- Schilling-type monocytic (M9890/3) - see Leukemia, monocytic
- stem cell (M9801/3) 208.0
- subacute NEC (M9802/3) 208.2
- subleukemic NEC (M9804/3) 208.8
- thrombocytic (M9910/3) 207.2
- undifferentiated (M9801/3) 208.0
|
|
|
